Ionis Pharmaceuticals Repriced Drug Ahead Of Key FDA Decision Signals Push Into Larger Market

All NewsMarch 26, 2026

Ionis Pharmaceuticals cuts Tryngolza price ahead of sHTG decision, with analysts seeing stronger sales potential and competitive positioning.

Latest Ratings for IONS

DateFirmActionFromTo Mar 2022GuggenheimInitiates Coverage OnBuy Mar 2022CitigroupInitiates Coverage OnSell Feb 2022SVB LeerinkMaintainsMarket Perform

View More Analyst Ratings for IONS

View the Latest Analyst Ratings

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent